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    Parasitic diseases cause major morbidity and 
mortality throughout the world. Among them 
intestinal parasites are widely prevalent and cause 
significant medical and public health problems. 
    World Health Organization reported that about 
3.5 billion people are affected worldwide and 450 
million are ill as a result of intestinal parasitic 
infections (1, 2). The prevalence of these parasites 
in developing countries varies depending on the 
environmental, economic, regional, political, 
cultural and social factors. In such countries, lack 
of access to healthcare, inadequate sanitation and 
malnutrition increase susceptibility to infection 
(3). The common transmission ways of these 
infections are contaminated food or drinking 
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Background: Despite continued and comprehensive planning of the world health 
organization (WHO), intestinal parasitic infections are a serious public problem in 
developing countries. Due to the high prevalence of cancers in Ardabil province and 
subsequently the high possibility of intestinal parasitic infections among the people, 
the aim of this study was to assess the frequency of intestinal parasites in patients 
with malignancy in this area. 
Methods: In this cross-sectional study, 100 fecal samples were collected from 
patients with cancer during February to September 2015. The specimens were 
examined for intestinal parasites using direct smear, formal-ethyl acetate 
concentration, agar plate culture and Ziel-Neelsen staining technique. 
Results: The overall frequency of intestinal parasitic infections in studied cancer 
patients was 10%. The infection rates of detected intestinal parasites were 
Cryptosporidium spp. oocyst 4%, Blastocystis hominis 3%, Giardia lamblia 2% and 
Taenia spp. 1%. 
Conclusion: Despite the low frequency of intestinal parasites, there is a need to 
screen cancer patients for some important parasitic infections such as 
Cryptosporidium spp. and Strongiloides stercoralis because of irreparable effects of 
those parasites on the patients and to increase awareness among clinicians regarding 
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water, and they may also spread from person to 
person by fecal-oral contact (4). Furthermore, the 
roleof immune system in acquisition of these 
infections are inevitable. Immune system plays an 
important role in modifying the establishment of 
infection, controlling disease, limiting the severity 
and dissemination of the disease, and assisting in 
clearance or control of the parasite (5). However, 
in cancer and AIDS patients the severity and rate 
of parasitic diseases progression are compounded. 
During the past decades major advances in 
medicine have enabled patients with cancer to live 
prolonged productive lives though the result of 
these achievements is a main deficiency of the 
host -defense mechanisms that puts the patients at 
the risk of parasitic infections Cancer individuals 
are more susceptible to acquire infection, and after 
exposure they show more severe disease once the 
infection is established. Infection disseminates 
rather than being localized and patients are unable 
to clear parasites leading to greater morbidity and 
mortality in these patients (6). In recent years, 
with increasing the number of susceptible hosts 
and use of novel immunosuppressive drugs the 
frequency of parasitic infections has increased in 
such patients (7). About 340 parasitic species 
infect more than three billion people worldwide.  
    Some of the common parasites found in 
immunosuppressed patients are Giardia lamblia, 
Entamoeba histolytica, Strongyloides stercoralis, 
Cryptosporidium parvum, Cyclospora 
cayeatanensis, Isospora belli, and Microsporidia 
spp. In spite of recent increases in people with 
various cancers in Iran, there are only very few 
studies about the prevalence of parasitic infections 
in this population (8-10). This study was carried 
out in order to investigate the frequency of 
intestinal parasites in fecal samples of cancer 
patients in Ardabil province, northwest Iran. 
2. Material and Methods 
2.1. Study area 
    Ardabil province, a mountainous land, is 
located in the north west of Iran and has an area of 
18,011 km² with a population of 1.6 million 
people, where 46% of people live in urban areas. 
Its coordinates are 38°15′05″N and 48°17′50″E. 
This province is divided into two geographical 














2.2. Sample collection 
    The current cross-sectional study was conducted 
from February to September 2015. During the 
study period a total of 100 samples were collected 
from cancer individuals (figure 2). Patients were 
first requested to complete a questionnaire. The 
questionnaire included the following information: 
age, sex, location, level of education, occupation, 
kind of disease, history of contact with animals, 
history of anti-parasitic drugs and drinking water 
sources. All patients had weakened immune 
system due to chemotherapy. 
   The fecal samples were collected freshly in stool 
specimen containers, which were properly labeled. 
The samples were transferred to the Department of 
Parasitology, School of Medicine, Ardabil 
University of Medical Sciences, and were stored at 
4°C for further microscopic examination. 
     
 
Fig. 1: Geographic location. (A) Location of Ardabil 
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2.3. Parasitological procedures 
    All specimens were microscopically examined 
with saline and iodine wet mounts for detection of 
protozoan oocysts, cysts, helminthic eggs and 
larvae before concentration using sieving and 
flotation. To diagnose Strongyloides stercoralis 
larvae in stool samples nutrient agar culture was 
performed. In the agar plate method, 2 grams of 
specimens were placed in the center of an agar 
medium in a 9cm plastic Petri dish, then covered 
and sealed round the edge with adhesive tape, and 
incubated at room temperature (about 28°C) for 
48h. Thereafter, plates were examined under a 
compound microscope with a green filter at 40 
magnification.  Fecal samples were collected in 
10% formaldehyde and processed by Formalin-
Ethyl Acetate sedimentation concentration 
methods. First, fecal suspension was passed 
through the gauze placed over a 15ml conical 
centrifuge tube. 
    Second, 3ml of ethyl acetate was added and 
shaken vigorously in an inverted position for 30 
seconds and then centrifuged at 2000 rpm for 1 
minute. Finally debris from the top of the tube was 
removed and several drops of concentrated 
specimen were transferred to the slide. Each 
sample was microscopically examined. 
Identification of parasites was carried out by 
morphological characteristics. In addition, samples 
were screened by means of a modified Ziehl- 
Neelsen method. A thin smear was made of the 
pellet obtained from the Sedimentation 
concentration methods and stained by the 
modified Ziehl-Neelsen technique. 
    After staining, the smear was examined at 100X 
magnification for detection of Cryptosporidium 
spp. oocysts in stool samples (11). A sample was 
recorded as positive if at least one parasitic form 
was observed. 
2.4. Statistical analyses 
    Statistical analyses were conducted using the 
Statistical Package for the Social Sciences (SPSS) 
software program for Windows version 16.0. The 
differences between the groups of categorical 
variables were analyzed by chi-square test. 
    The level of statistical significance was set at p 
< 0.05. 
3. Results and Discussion 
    The results confirmed the overall frequency rate 
of parasitic infections as 10% (10 patients). 
    Stool cultures on nutrient agar plates for 
detection of Strongyloides stercoralis larvae 
showed no infection. The highest rate of infection 
was related to Cryptosporidium spp. oocysts 4% 
(4 patients) and frequencies of other parasites were 
as follows: Blastocystis hominis 3% (3 patients), 
Giardia lamblia 2% (2 patients) and Taenia spp 1 
% (1 patient) respectively (Table 1).  
    Among the patients who participated in the 
study, 41% were female and 59% male and the 
study showed that there was no significant 
association between sex and parasite infection (p = 
0/839).  Age distribution of the patients showed 
that the majority of patients belonged to the age 
group of 40-60 and no significant association was 
observed with parasite infection (p = 0/751). In 
case of educational status, most patients were 
 
Fig. 2: Distribution of the different types of cancer in 
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uneducated (44 %) and the results did not exhibit 
any significant relation (p = 0/637).  
Table 1: The number of parasites found in cancer 
individuals who participated in the study. 





 Taenia spp 1 1% 
Blastocystis hominis 3 3% 
Giardia lamblia 2 2% 
Cryptosporidium spp 4 4% 
Total 10 10% 
 
    In this study  the majority of patients (32%) 
suffered from lymphoma, but a significant 
association between positive cases and type of 
cancer was not observed (p = 0/637). In 
addition,the results of the study showed that 
infection with intestinal parasites is not 
statistically significant related to residence (p < 
0.288) and drinking water source (p = 0/094) 
(Table 2). Healthy immune system protects the 
body against infections especially parasitic 
infections but in cancer patients, suppressed 
immune system by chemotherapy predisposes 
them to protozoan and helminthic infections which 
are responsible for considerable morbidity and 
mortality. These infections have been variably 
reported among cancer individuals from various 
parts of Iran; however, data in Ardabil province 
has been limited. In this study, we evaluated the 
frequency of intestinal parasites in cancer 
individuals. 
    Intestinal parasitic infections showed low 
prevalence in our population with an overall rate 
of 10%. This frequency is lower than those 
previously reported in other studies conducted in 
Nepal (36.9%) and in India (53.02%) (6, 12).  
    This discrepancy could be explained by health 
condition of study area and the sample size. 
    According to our findings, 4% of patients tested 
positive for Cryptosporidium spp. oocysts. Our 
results were similar to the studies conducted in 
Saudi Arabia (8%), Colombia (3.6%) and Turkey 
(5.2 %) (13-15). Cryptosporidiosis represents a 
major public health problem. This infection has 
been reported worldwide, and its prevalence varies 
in different regions (16). In developing countries, 
Cryptosporidiosis remains a clinically significant 
opportunistic infection in immunodeficiency 
patients, causing potentially life-threatening 
diarrhea (17). Previous studies in Iran 
demonstrated that 0.3- 3% of immunodeficiency 
patients were infected with this pathogen (18). 
Despite Ziehl-Neelsen staining is gold standard 
detection method, it seems that the new methods 
such as ELISA technique could be used as a 
complementary test to yield better detection 
results for this pathogen (19). Many studies have 
been carried out on the frequency of intestinal 
parasites among patients with malignancies in Iran 
and the results revealed Giardia lamblia  and 
Blastocystis hominis frequencies between 1 to 8% 
and 0.4- 5.1% respectively (8, 10). In this study 
our results were in line with studies discussed and 
frequency rates of Blastocystis hominis and 
Giardia lamblia were 3% and 2% respectively 
(20, 21). The results of stool cultures on nutrient 
agar plates showed no infection with 
Strongyloides stercoralis larvae. Strongyloides 
stercoralis is an intestinal nematode of humans 
with a worldwide distribution, affecting about 100 
million humans (22, 23). Although most infected 
individuals are asymptomatic all patients are at 
risk of developing severe complicated 
Strongyloidiasis, particularly if they are 
immunosuppressed by chemotherapy like cancer 
patients. In our study, Taenia spp were isolated 
from 1 % of patients. This result is in accordance 
with other studies conducted in Nigeria and India 
(24, 25). To our knowledge, this is the first study 
of parasitic intestinal infections in cancer 
individuals in Ardabil and it shows the importance 
of intestinal pathogens for the screening process 



































120                                                                                                                    Intestinal Parasites in Patients with Malignancy 
Mohammadi-Ghalehbin B et al/ J. Hum. Environ. Health Promot. 2017; 2(2):118- 124 
Regarding the fact that enteric parasites can cause 
serious complications and interfere with disease 
control, the screening policy for intestinal 
parasites should continue. In spite of the low 
frequency of parasitic intestinal infection in our 
study, a prospective case control study with more 
participants would perhaps help us to present 
important epidemiological information between 
cancer individuals and intestinal parasites in this 
region. We recommend larger and well-designed 
studies to evaluate the association of parasitic 
infections with other immunocompromising 
infections. Stool parasite examination is 
recommended before chemotherapy for cancer 
patients suffering from parasitic diseases. 
 
Table 2: Sociodemographic distribution of cancer individuals participating in the study. 
Risk factors for parasitic infection Patients (%) p-value 
Gender 
 Male 59  
p=0/839  Female 41 
Age (year) 
 0-20 1  
 
p=0/751 
 20-40 21 
 40-60 42 
  ˃60 36 
Educational status 
 Uneducated 44  
 
p=0/637 
 Read and write 17 
 Elementary school 14 
 High school and above 25 
Location 
 Urban 64  
p=0/288  Rural 36 
Contacted with animals 
 Yes 27  
p=0/540  No 73 
Anti-parasitic drugs usage 
 Yes 5  
p=0/41  No 95 
Drinking water source 
 Piped water 77  
p=0/094  Bore holes  15 
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